In-hospital mortality from liver resection for hepatocellular carcinoma: A simple risk score

Cancer

Volumn 116, Issue 7, 2010, Pages 1733-1738

  Simons, Jessica P ^a   Ng, Sing Chau ^a   Hill, Joshua S ^a   Shah, Shimul A ^a   Zhou, Zheng ^a   Tseng, Jennifer F ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Hepatocellular carcinoma; In hospital mortality; Liver resection; Nationwide inpatient sample; Risk score

Indexed keywords

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DECISION MAKING; DEMOGRAPHY; ENUCLEATION; FEMALE; HOSPITAL PATIENT; HUMAN; LIVER CELL CARCINOMA; LIVER LOBECTOMY; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; SCORING SYSTEM; VALIDATION PROCESS;

AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATECTOMY; HOSPITAL MORTALITY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RISK ASSESSMENT;

EID: 77950211247     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24904     Document Type: Article

References (25)

1. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med. 2003;139:817-823.
2. Hemming AW, Reed AI, Howard RJ, et al. Preoperative portal vein embolization for extended hepatectomy. Ann Surg. 2003;237:686-691.
3. Ng KK, Vauthey JN, Pawlik TM, et al. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol. 2005;12:364-373.
4. Hemming AW, Reed AI, Fujita S, et al. Role for extending hepatic resection using an aggressive approach to liver surgery. J Am Coll Surg. 2008;206:870-875.
5. Hart AC, Stegman MS, Ford B, eds. ICD-9-CM Professional for Physicians: International Classification of Diseases, 9th Revision, Clinical Modification. Salt Lake City, Utah: Medicode Publications; 2001.
6. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
7. Romano PS, Roost LL, Jollis JG. Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46:1075-1079.
8. Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg. 2002;236:397-406.
9. Helling TS. Ruminations of an ordinary hepatic surgeon: a journey through the pitfalls of major liver resections. J Gastrointest Surg. 2002;6:625-629.
10. Ston ME Jr, Rehman SU, Conaway G, Sardi A. Hepatic resection at a community hospital. J Gastrointest Surg. 2000;4:349-353.
11. Vauthey JN, Pawlik TM, Abdalla EK, et al. Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg. 2004;239:722-730; discussion 730-732.
12. Virani S, Michaelson JS, Hutter MM, et al. Morbidity and mortality after liver resection: results of the patient safety in surgery study. J Am Coll Surg. 2007;204:1284-1292.
13. Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg. 1964;1:1-85.
14. Schneider PD. Preoperative assessment of liver function. Surg Clin North Am. 2004;84:355-373.
15. Song T-J, Wai Kit Ip E, Fong Y. Hepatocellular carcinoma: current surgical management. Gastroenterology. 2004;127(5 suppl 1):S248-S260.
16. Yanaga K. Current status of hepatic resection for hepatocellular carcinoma. J Gastroenterol. 2004;39:919-926.
17. Belghiti J, Hiramatsu K, Benoist S, et al. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg. 2000;191:38-46.
18. Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer. 1985;56:918-928.
19. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19:329-338.
20. Kudo M, Chung H, Osaki Y. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol. 2003;38:207-215.
21. Ikai I, Yamamoto Y, Yamamoto N, et al. Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins. Surg Oncol Clin North Am. 2003;12:65-75, ix.
22. American Joint Committee on Cancer. Liver (including intrahepatic bile ducts). In: Green FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Handbook. 6th ed. New York: Springer; 2002:131-144.
23. Pawlik TM, Tseng JF, Vauthey J-N. Controversies in the staging of hepatocellular carcinoma. Cancer Rev Asia Pacific. 2003;1:179-189.
24. Seo YS, Kim YJ, Um SH, et al. Evaluation of the prognostic powers of various tumor status grading scales in patients with hepatocellular carcinoma. J Gastroenterol Hepatol. 2008;23(8 pt 1):1267-1275.
25. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464-470.